Back to Man Group plc Man Group plc

CCCCCCCC

Showing 6 of 15 quarters

Position history for Man Group plcMan Group plc's holdings in C4 Therapeutics, Inc.

Yes. Man Group holds 408,648 shares of CCCC (C4 Therapeutics), worth $1.9M, as of its Q2 2026 13F filing. It increased the position by 152,180 shares (+59.3%) from Q1 2026. Man Group has held CCCC since Q1 2025, across 6 quarterly 13F filings.

Current Value

$1.9M

Current Shares

408,648

Total Value Change

+$1.8M

Total Shares Change

+323,025

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
408,648
+59.3%
$1.9M0.0%$4.67
37
2026-Q1
Increased
256,468
+64.3%
$674,5110.0%$2.63
36
2025-Q4
Increased
156,098
+72.9%
$298,1470.0%$1.91
35
2025-Q3
Increased
90,278
+15.0%
$200,4170.0%$2.22
26
2025-Q2
Decreased
78,487
-8.3%
$112,2360.0%$1.43
0
2025-Q1
New
85,623
—
$136,9970.0%$1.60
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used